FDA’s OPQ Emerging Tech Program Plans to Help Sponsors Avoid Manufacturing Quality Failures

Drug Industry Daily
A A
The FDA plans to use its emerging technology program to help address key pharmaceutical quality and manufacturing challenges — and also train agency reviewers on the latest processes to keep pace with industry innovation.

To View This Article:

Login

Subscribe To Drug Industry Daily